Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-centre, Observational Study to Evaluate Immune Response to Covid-19 Vaccines in Immunocompromised Patients With Haematological Disorders

NCT04805216 is registered in ClinicalTrials.gov with University Hospitals of North Midlands NHS Trust as lead sponsor.

NCT NCT04805216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04805216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-centre, Observational Study to Evaluate Immune Response to Covid-19 Vaccines in Immunocompromised Patients With Haematological Disorders
Lead sponsor
University Hospitals of North Midlands NHS Trust
Phase
Observational
Overall status
Completed
Start date
March 15, 2021
Completion date
July 31, 2022
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, haematological disorders, immune suppression